Sg3 Management, LLC Bio N Tech Se Call Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $919,275 - $1.15 Million	-7,500 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$127.65 - $183.11 $957,375 - $1.37 Million	7,500 New	7,500 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $957,375 - $1.37 Million	7,500 New	7,500 $1.01 Million
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $3.58 Million - $6.46 Million	62,000 New	62,000 $4.29 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.